
Y Glim M 1mg/500mg Tablet SR
Marketer
VHVL Inc
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Y Glim M 1mg/500mg Tablet SR
Metformin/glimepiride extended-release tablets (1mg/500mg) are classified as antidiabetic agents, combining two medications for adult type 2 diabetes management. This dual-action therapy helps regulate blood glucose. These tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-controlled blood sugar; abrupt cessation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests assessing blood cell counts and liver function, are recommended by your doctor.
Primary Ingredients of Y Glim M 1mg/500mg Tablet SR
No text provided. Please provide the text you want me to rephrase.
Uses of Y Glim M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Y Glim M 1mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Y Glim M 1mg/500mg Extended-Release tablets should be taken with a meal.
Common Side effects of Y Glim M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Y Glim M 1mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Y Glim M 1mg/500mg sustained-release tablet should be taken with a meal.
How Y Glim M 1mg/500mg Tablet SR works:
Y Glim M 1mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Y Glim M 1mg/500mg Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Y Glim M 1mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Prolonged-release Y Glim M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Caution is advised when administering Y Glim M 1mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Patients with severe kidney disease should not use Y Glim M 1mg/500mg SR tablets. A physician's consultation is recommended. Routine monitoring of kidney function is prudent during treatment with this medication.
LiverCAUTION
Patients with liver impairment should use Y Glim M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advisable. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, the medication is contraindicated in patients with severe liver dysfunction.
What if you forget to take Y Glim M 1mg/500mg Tablet SR :
Should you forget to take a Y Glim M 1mg/500mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Y Glim M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
